chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Numbness in left arm and neck; Vice grip feeling around heart; Injection site pain; Headache; Nausea; Muscle pain; Extreme tiredness; This is a spontaneous report from a contactable consumer, the patient. A 62-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8729) via an unspecified route of administration in the left arm on 12Apr2021 at 10:00 (at the age of 62-year-old) as a single dose for COVID-19 immunisation. Medical history included spondylolisthesis. The patient had allergies to medications (not specified). Concomitant medications included ibuprofen (MOTRIN) and paracetamol (TYLENOL) both for unknown indications from an unknown date and unknown if ongoing. It was unknown if the patient was diagnosed with COVID-19 prior to the vaccination. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 12Apr2021 at 10:15, the patient experienced injection site pain, headache, nausea, vice grip feeling around heart, numbness in left arm and neck, muscle pain and extreme tiredness. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19.The clinical outcome of the events injection site pain, headache, nausea, vice grip feeling around heart, numbness in left arm and neck, muscle pain and extreme tiredness was not resolved at the time of report.  No follow-up attempts are needed. No further information is expected.
Severe RIGHT deltoid pain, on-going since 2 days after injection. Pain was progressive since onset but has since stabilized as of 12/1/2019. Pain awakens me from sleep and causes decreased range of motion. Pain is worst when I have been at rest (after work in the evening, at night, early morning) and is improved throughout the day with activity. Pain reasonably well-managed with TID 1000 mg acetaminophen, OTC lidocaine 4% patch at night, and heat PRN. If I do not take these measures, I awaken at night with severe pain and am unable to move my RIGHT arm without the assistance of my LEFT arm.
Shivers, Weak Legs, increased heart rate and blood pressure, fever (103). After 30-45 minutes of getting vaccinated, patient got reaction, had to call 911 and transferred to urgent care
There was NO adverse event. The parent was not truthful about her son's age and told us he was 11 multiple times. She asked several times to make sure he was getting Pfizer for kids. The patient turned out to be 13. He was given the wrong shot. We were advised by VAERS customer service to report this anyway.
Patient received Pfizer COVID vaccine on 2/3/21 and 3/19/21. On 8/18/21, patient presented to our ED  Medical Center and ended up being admitted for acute hypoxemic respiratory failure due to COVID-19 pneumonia and acute uncompensated COPD/emphysema exacerbation. As of today (8/20/21), patient is still admitted in the med/surg unit.
I just got back from a trip, my husband got up the day before feeling poorly and tested positive for COVID-19. I woke up the next day feeling bad with a headache, cough, fever, muscle aches and pain, fatigue. I used a BianaxNow home COVID-19 test that came back positive in fifteen minutes. I called the doctor's office, it was Holiday Day weekend, so they did not get back to me until Tuesday. I was prescribed Paxlovid that I started taking immediately once it was filled at the pharmacy. I started to feel better once I started taking it.
Having some side effects listed but 23 days after receiving vaccine; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION COMPLICATION (Having some side effects listed but 23 days after receiving vaccine) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 044A21A) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced VACCINATION COMPLICATION (Having some side effects listed but 23 days after receiving vaccine). At the time of the report, VACCINATION COMPLICATION (Having some side effects listed but 23 days after receiving vaccine) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications reported by investigator No treatment medications provided by the reporter.
muscle aches, fever of 102, headache, fatigue, nausea, redness at the site of injection, muscle pain at the injection site.
Day 6 post injection continue to have slight pain and swelling at injection site since administration, today noticed it to be superficially itchy.  Last night at 2300 I had taken a benadryl, and the current time is 1400 and the itchiness I suspect is due to the benadryl wearing off.
flu-like symptoms; runny nose; sore throat; coughing after 15 mins from getting the dose which got worse; This is a spontaneous report from a Pfizer-sponsored program. A contactable female consumer (patient) of an unspecified age received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: Solution for injection, Lot number: unknown) dose 1 via an unspecified route of administration on 06Apr2021 as dose 1, single for covid-19 immunisation. The patient medical history and concomitant medications were not reported. On an unspecified date, the patient experienced flu-like symptoms, runny nose, sore throat and coughing after 15 mins from getting the dose which got worse. The outcome of the event was unknown.  No follow-up attempts are needed. No further information is expected.
This spontaneous report as received from a Medical assistant refers to an unknown number of patients of unknown age and gender. The reporter mentioned that an unknown number of patients have received VARIVAX (Merck) (lot number and expiry date not reported) (dosing regimen and frequency unknown) from January 2013 to 16-DEC-2013 that may had an unknown number of excursions with temperatures from 3 degrees C to 7 degrees C and each excursion being 64 hours. No adverse effects reported. No product quality issue was reported. Follow-up information has been received from a medical assistant (who called to report specific administration dates), concerning a patient of unknown age and gender. On 02-APR-2013 the patient had received a dose of VARIVAX (Merck) (lot number # H011233, exp. date: 06-JUN-2014) (dosing regimen and frequency were not provided). This dose of VARIVAX (Merck) had an unknown number of excursions with temperatures from minus 3 Celsius degree to minus 7 Celsius degree and each excursions being 64 hours. No adverse experiences were reported. This is one of 9 reports from the same source (# 1312USA011519; #1312USA011525; #1312USA008561; #1312USA011521; #1312USA011522; #1312USA011523; #1312USA011524; #1312USA011526). Additional information has been requested.
Have not received second dose (>35 days have passed)/first dose on 28Jul2021; This spontaneous case was reported by a consumer and describes the occurrence of PRODUCT DOSE OMISSION ISSUE (Have not received second dose (>35 days have passed)/first dose on 28Jul2021) in a 46-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 026C21A) for COVID-19 vaccination.     No Medical History information was reported.    On 28-Jul-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced PRODUCT DOSE OMISSION ISSUE (Have not received second dose (>35 days have passed)/first dose on 28Jul2021). At the time of the report, PRODUCT DOSE OMISSION ISSUE (Have not received second dose (>35 days have passed)/first dose on 28Jul2021) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment information was not provided. List of concomitant medication were not given.
Headaches; Light dizziness; Dose 1:31Jul2021, Dose 2: 14Aug2021; This is a spontaneous report from a contactable consumer, the patient. A 31-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0180) via an unspecified route of administration in the left arm on 14Aug2021 at 12:00 (at the age of 31-years-old) as a single dose for COVID-19 immunisation. The patient had no medical history and no known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot number: EW0202) via an unspecified route of administration on 31Jul2021 at 13:00 (at the age of 31-years-old) as a single dose for COVID-19 immunisation. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. On 15Aug2021 at 01:00, the patient experienced headaches and light dizziness when she stood up. It was reported that it had been six days and she was still getting it. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event headaches and light dizziness were not resolved at the time of this report.   No follow-up attempts are possible. No further information is expected.
my heart rate is really fast and like strong in my chest; had the heart beat at the skip and she pace out some time; patient received it on 24Jul2021 and the next one she received on 22Dec2021; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 47-year-old female patient received BNT162b2 (BNT162B2), on 22Dec2021 as dose 2, single (Lot number: EW0158, Expiration Date: 31Jul2021) at the age of 47 years. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: BNT162b2 (DOSE 1, SINGLE, LOT: FL3197, Expiration date: Jun2022), administration date: 24Jul2021, when the patient was 46-year-old, for COVID-19 Immunization. The patient had never been diagnosed with diabetes. She did not take regular medication and did not take anything daily. The patient received it on 24Jul2021 and the next one she received on 22Dec2021. The patient stated she had a life threatening side effect from it. The patient had real speeding heart rate and she never had it before until she got the vaccine. She did not stop drinking coffee and drank water and still cannot stop the racing heart. On her first thought, she thought it was anxiety so she took anxiety medicine but her heart still racing. She just got on 'medicine' because of her heart and she had to stop working and now I was trying to get her disability. She just had the heart beat at the skip and she pace out some time. The patient reported heart rate was really fast and like strong in her chest, it did not hurt yet but it was like she got a pain 'even on' but her heart beat is beating really fast. Before that, she had never had these problems. The patient underwent the following laboratory tests and procedures: Electrocardiogram: unknown results. Therapeutic measures were taken as a result of heart rate increased, extrasystoles.  No follow-up attempts are possible. No further information is expected.; Sender's Comments: Linked Report(s) : US-PFIZER INC-202201313200 same reporter, different event;
outbreaks of herpes zoster; Information has been received from a lawyer concerning a case in litigation and refers to a female patient of unknown age. The patient's concurrent conditions, medical history, historical drugs and concomitant therapies were not reported.      On an unknown date, the patient was vaccinated with zoster vaccine live (ZOSTAVAX) (dose, route, lot number and expiration date were not reported) for routine health maintenance and for its intended purpose: the prevention of shingles.   On an unknown date, the patient suffered multiple outbreaks of herpes zoster and was treated by medical providers.      The outcome of herpes zoster was not recovered/not resolved.     The reporter considered herpes zoster to be related to Zoster Vaccine Live (ZOSTAVAX).     The patient's symptoms had resulted severe and permanent personal injuries.
Narrative:  PATIENT WAS IMMUNIZED IN A TIMELY MANNER WITH PFIZER MRNA VACCINE 4/21/21 AND 5/12 RESPECTIVELY. PATIENT WAS INPATIENT FOR STROKE REHAB WHEN HE CONTRACTED COVID. HE DECLINED MOST COVID TREATMENTS AND DID NOT QUALIFY FOR MONOCLONAL ABS. HE RECEIVED 02 SUPPORT UP TO 3L NC. WITH TIME, HE IMPROVED AND WAS TRANSFERED BACK FOR FURTHER REHABILITATION
Moderna inadvertently administered to a child under 18. NDC: 80777-273-10
patient had allergies; Initial information received on 27-Jan-2021 regarding an unsolicited valid non-serious case from physician.  This case involves patient (unknown demographics) who had allergic reaction (Hypersensitivity), after receiving INFLUENZA USP TRIVAL A-B SUBVIRION NO PRESERVATIVE VACCINE [FLUZONE].  Medical history, medical treatment(s), vaccination(s), concomitant medication(s) and family history were not provided.   On an unknown date, the patient received a dose of suspect INFLUENZA USP TRIVAL A-B SUBVIRION NO PRESERVATIVE VACCINE [lot number and expiry date not reported] via unknown route in an unknown administration site for prophylactic vaccination.  On an unknown date, the patient developed a non-serious allergic reaction (Hypersensitivity) (Unknown latency), following the administration of INFLUENZA USP TRIVAL A-B SUBVIRION NO PRESERVATIVE VACCINE.  No laboratory data reported.  It was not reported if the patient received a corrective treatment.  At the time of reporting, the outcome is unknown for the event.  There will be no information on the batch number to be requested for this case.
fever up to 104.3 w/inc irritability, crying, vomiting w/in 24 hrs of receiving vax; hospitalized from 20AUG to 23AUG w/o foci of infection identified; poss pertussis vax related;
I did well on my first two Moderna shots. My booster of course left a sore shoulder where the injection was given. The next day in the evening I noticed I had a really fall feeling in my left armpit and it was pretty painful. On the third day after the shot I noticed something that looked like wilting on my left breast. The pain under my armpits continued and the swelling down my left breast got worse. I emailed my doctor and let her know I was having what I believe to be a reaction. Due to the holiday she didn't get my call till the following Monday. She wanted to see me but at that point it had all stopped on Monday no swelling in my arm pit no welting on my left breast. So I declined a doctor visit.
Red raised swollen area covering the upper right arm. Was tender and hot to touch- Appeared to be cellulitis???  Reported the concern to my MD and was prescribed antibiotics, did not mention the COVID injection  (DID NOT correlate the symptoms until shot #2)
Treatment of COVID-19; Treatment of COVID-19; Interchange of vaccine products; This is a spontaneous report received from a contactable reporter(s) (Other HCP). The reporter is the patient.  A 71-year-old female patient (not pregnant) received BNT162b2, BNT162b2 omi ba.4-5 (BNT162B2, BNT162B2 OMI BA.4-5), on 03Oct2022 at 11:00 as dose 5 (booster), single (Lot number: GJ3277) at the age of 71 years, in right arm for covid-19 immunisation; elasomeran (MODERNA COVID-19 VACCINE), on 26Dec2020 as dose 1, single (Lot number: 025J202A), in left arm, on 23Jan2021 as dose 2, single (Lot number: 027L20A), in left arm, on 02Nov2021 at 10:00 as dose 3 (booster), single (Lot number: CUS9086), in left arm and on 19Apr2022 at 12:00 as dose 4 (booster), single (Lot number: 48L21A), in left arm for covid-19 immunisation. The patient's relevant medical history included: "controlled mild HTN" (unspecified if ongoing), notes: Other medical history: controlled mild HTN; "surgical removal of thyroid" (unspecified if ongoing), notes: Other medical history: surgical removal of thyroid. Concomitant medication(s) included: ESTRING, start date: Feb2022; HYDROCHLOROTHIAZIDE, start date: Aug1981; LEVOTHYROXINE, start date: Apr1994; SPIRONOLACTONE, start date: Feb1997. The following information was reported: INTERCHANGE OF VACCINE PRODUCTS (medically significant) with onset 03Oct2022 at 11:00, outcome "unknown"; DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant), outcome "not recovered" and all described as "Treatment of COVID-19". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: Positive, notes: Rebound Covid infection 7 days after finishing course of Paxlovid. Therapeutic measures were taken as a result of drug ineffective, covid-19.  Clinical course: Patient did not had any allergies.; Sender's Comments: The efficacy of a drug varies from patient to patient and can be affected by different factors, however a contributory role of the suspect drug BNT162B2 to the reported events Interchange of vaccine products, drug ineffective, COVID-19 cannot be ruled out.
03/05/2022, I woke up and started feeling kind of a crick in my neck but it was more painful than that but I didn't think much of it. I went the whole day as if nothing happened, and the next morning it was significantly more painful and I could feel swelling on the left side of my neck and I wasn't able to tilt my head and the pain started getting worse so I took Ibuprofen which didn't help. The next day 03/07/2022, I woke up and my neck was very swollen and stiff on the left side and I tried working but if I was in a position other than lying down I had a headache that started at the base of my neck into the left side of my head, like a migraine. I ended up taking 600 mg Ibuprofen and that didn't help so I tried Naproxen and Aleve and that didn't help either. 03/08/2022 the pain wasn't getting better and I couldn't tilt or rotate my head so I did a virtual doctor's appointment and the Doctor said to keep taking Ibuprofen and wait it out. I was in a state of pain for a week, and on Monday and Tuesday I couldn't work but half of a day because of the pain. Saturday 03/12/2022 it started to hurt less and I was able to tilt my head again, and on 03/13/2022 it was better and I was able to do things as normal but still got a headache if I sat up too long.
Stated left clinic after flu shot - 7-8 minutes after leaving started smelling musty odor.  Got home and felt strange, started to feel heart rate increase, dizzy, face flushed red.  Many allergies, went to immediate care center.  All symptoms resolved except musty odor.
PT RECEIVED PROQUAD (VARACELLA) R THIGH 3/31/22 SHE HAD REDNESS @ INJECTION SITE, LOW GRADE FECVERS, IRRITABILITY AND LOSS OF APPETITE ON 4/10/22 DEVELOPED FULL BODY HIVES, QUARTER SIZED-REDNESS AT INJECTION SITE OF  R THIGH
Significant menstruation irregularities. With full 5-7 day menstruation and only 3-6 days between start of next menstruation. Began the following month of first injection.
site of injection is itching; site of injection developed red mark; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PRURITUS (site of injection is itching) and VACCINATION SITE ERYTHEMA (site of injection developed red mark) in a 42-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 01-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 01-Feb-2021, the patient experienced VACCINATION SITE PRURITUS (site of injection is itching) and VACCINATION SITE ERYTHEMA (site of injection developed red mark). At the time of the report, VACCINATION SITE PRURITUS (site of injection is itching) and VACCINATION SITE ERYTHEMA (site of injection developed red mark) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medications reported were Benadryl Benadryl, Cortisone cream Cortisone cream for drug use for unknown indication. Treatment details included Benadryl, Cortisone Cream.
expired dose of pentacel administered to a patient with no reported adverse event; Initial information received on 15-Aug-2022 regarding an unsolicited valid  non-serious case received from a physician.  This case involves a 3 years old male patient who was administered expired dose of diphtheria/tetanus/5 hybrid AC pertussis/IPV(MRC5)/HIB(PRP/T) vaccine [Pentacel] with no reported adverse event.  The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.  Concomitant medications included VARICELLA ZOSTER VACCINE (VARICELLA VACCINE) for Prophylactic vaccination; MEASLES VACCINE, MUMPS VACCINE, RUBELLA VACCINE (MMR) for Prophylactic vaccination; PNEUMOCOCCAL VACCINE CONJ (PNEUMOCOCCAL CONJUGATE VACCINE) for Prophylactic vaccination; and HEPATITIS A VACCINE (HEPATITIS A) for Prophylactic vaccination.  On 12-Aug-2022, the patient received 0.5 mL dose of suspect diphtheria/tetanus/5 hybrid AC pertussis/IPV(MRC5)/HIB(PRP/T) vaccine (formulation and strength not reported; lot UJ474AAA, expiry date: 09-Jul-2022) via intramuscular route in the thigh nos for immunization.  On 12-Aug-2022, the patient was administered expired dose of diphtheria/tetanus/5 hybrid AC pertussis/IPV(MRC5)/HIB(PRP/T) vaccine with no reported adverse event (expired product administered).  It was reported, "an expired dose of PENTACEL administered to a patient. Requesting validity information. This situation is reported as a medication error due to expired dose of PENTACEL being administered".  Action taken was not applicable.  At time of reporting, the outcome was Unknown for the event.  This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the guidelines. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.
10/1/2021- slurring his speech, not able to drink without spilling down self, face sore and drooling, pain in the back of head and could hear heart beat in left ear
3/29/2009 Was hospitalized with meningococcal meningitis and bacteremia.  6/24/09 Hospital ER records received DOS 3/29/09. Assessment: Meningitis, diabetes. Patient presents with worsening headache, stiff neck, photophobia, fever, malaise, nausea and vomiting. Petechial rash, purpura both ankles. Transfered to higher level facility.  6/18/09 ICD-9 codes received. 3209, 25001, V5567, 78060  7/8/09 Hospital records received DOS 3/29/09 to 4/1/09. Assessment: Neisseria meningitidis meninigitis, insulin dependent diabetes. Patient presented with 24 hour fever, nuchal rigidity, and rash with petechia and purpuric lesions on all extremities. Vomiting, minimal oral intake. Tachycardia. Thin, dehydrated, and poorly perfused. Lips dry. Warm, flushed, pink. Myalgia, chills.
Hospitalization for COVID19, hypoxic respiratory failure, CHF. Treated with baricitinib 4 mg daily, Remdesivir, dexamethasone, zinc 50 mg daily, vitamin D3 50 mcg daily and vitamin C 1,000 mg daily. Discharged home 1/13/22
Developed shakiness after vaccine. Denies chest pain, SOB, trouble breathing or swallowing, or rash.  SpO2 100% RA  Respirations 16, unlabored.  BP 172/94, 175/89 HR 86, 69